Autobio Diagnostics Co., Ltd. vs CareDx, Inc
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- CareDx, Inc is the larger company by market value: $3.4 B against $2.9 B for Autobio Diagnostics Co., Ltd., 1.1 times as much (market caps of Aug 1, 2026 for Autobio Diagnostics Co., Ltd. and Oct 19, 2026 for CareDx, Inc). Autobio Diagnostics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Autobio Diagnostics Co., Ltd. had more revenue: $548 M in the year to December 2021 against $380 M for CareDx, Inc in the year to December 2025.
- Autobio Diagnostics Co., Ltd. made a net profit of $142 M, while CareDx, Inc made a net loss of $21 M.
- Autobio Diagnostics Co., Ltd. keeps more of each dollar of sales: a net margin of 25.9% against -5.6% for CareDx, Inc.
- On price to earnings, CareDx, Inc trades at 26.1× and Autobio Diagnostics Co., Ltd. at 20.7×: investors pay more for each dollar of CareDx, Inc's profit.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Autobio Diagnostics Co., Ltd. 603658.SS · #5,082 in the world | CareDx, Inc CDNA · #4,672 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇳 China | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1999 | 1998 |
| Size | ||
| Market cap | $2.9 B | $3.4 B |
| Revenue | $548 M | $380 M |
| Net income | $142 M▲ best | $-21 M |
| Employees | — | 645 |
| Valuation | ||
| P/E ratio | 20.7× | 26.1× |
| Price to sales | 5.4× | 6.8× |
| Price to book | 2.7× | 11.1× |
| Free cash flow yield | — | -0.2% |
| Profitability | ||
| Operating margin | — | -8.1% |
| Net margin | — | -5.6% |
| Return on equity | — | -6.3% |
| Growth | ||
| Revenue growth | — | 13.8% |
| Revenue growth, 3 years a year | — | 5.7% |
| Shareholder returns | ||
| Shareholder yield | — | 2.6% |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Aug 2026 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Autobio Diagnostics Co., Ltd. or CareDx, Inc?
CareDx, Inc is the larger company by market value: $3.4 B against $2.9 B for Autobio Diagnostics Co., Ltd., 1.1 times as much (market caps of Aug 1, 2026 for Autobio Diagnostics Co., Ltd. and Oct 19, 2026 for CareDx, Inc). Autobio Diagnostics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Autobio Diagnostics Co., Ltd. or CareDx, Inc?
Autobio Diagnostics Co., Ltd. had more revenue: $548 M in the year to December 2021 against $380 M for CareDx, Inc in the year to December 2025. Autobio Diagnostics Co., Ltd. made a net profit of $142 M, while CareDx, Inc made a net loss of $21 M.
Which is more profitable, Autobio Diagnostics Co., Ltd. or CareDx, Inc?
Autobio Diagnostics Co., Ltd. keeps more of each dollar of sales: a net margin of 25.9% against -5.6% for CareDx, Inc.
Is Autobio Diagnostics Co., Ltd. cheaper than CareDx, Inc?
On price to earnings, CareDx, Inc trades at 26.1× and Autobio Diagnostics Co., Ltd. at 20.7×: investors pay more for each dollar of CareDx, Inc's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
More about Autobio Diagnostics Co., Ltd.
More about CareDx, Inc
Sources#
Every figure on this page comes from these, with the date shown next to it.